National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-human chorionic gonadotropin vaccine
A peptide vaccine consisting of the whole or partial beta subunit of human chorionic gonadotrophin hormone (hCG), linked to an adjuvant carrier of bacterial or viral origin, with anti-fertility activity. Anti-human chorionic gonadotropin vaccine blocks the activity of hCG which is naturally produced by the trophectoderm of the pre-implantation embryo within a few days of fertilization. hCG is required for the maintenance of the corpus luteum in the ovary thus ensuring its continued production of progesterone, which is required for the successful completion of implantation of the blastocyst. Without progesterone, the corpus luteum regresses, and menstruation is initiated. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:anti-EpCAM antibody fragment -Pseudomonas exotoxin fusion protein, anti-EpCAM antibody fragment-bouganin fusion protein, anti-FLT-1 ribozyme, anti-GP-3 monoclonal antibody, anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968
Next:anti-IGF-1 receptor human monoclonal antibody R1507, anti-IGF-1R fully human monoclonal antibody AMG-479, anti-IGF-1R recombinant monoclonal antibody BIIB022, anti-IGF-1R recombinant monoclonal antibody MK-0646, anti-IGF-1R recombinant monoclonal antibody SCH 717454

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov